$HIMS came very close to the invalidation line on Friday but managed to hold above it and is looking to regain all losses in the PM now from Friday, up 3.6%.
$HIMS have announced that they have appointed Kare Schultz to their board, he was was the CEO of Teva pharmaceutical and President and COO of $NVO.
His statement today:
"Hims & Hers is on a trajectory to upend the healthcare industry," said Kåre Schultz. "In my long career in the pharmaceutical industry, this is the first company I have seen that is leveraging today’s modern tools to truly break down barriers and change the status quo of how people access the health solutions they need to live their fullest lives. I’m thrilled to be a part of this journey."
This is likely what $HIMS needs to solidify itself as a big player in the market and gives it the support it needs from attacks, which we have seen over the last 2 months.
I look forward to their earnings on the 5th of August and I expect it to be a positive beat.
Karnick
2024-07-23 14:31:13 +0000 UTCByron Tanigawa
2024-07-23 02:51:57 +0000 UTCTHESTOCKS
2024-07-22 13:24:30 +0000 UTC